Ever Source Wealth Advisors, LLC Biomarin Pharmaceutical Inc Transaction History
Ever Source Wealth Advisors, LLC
- $2.2 Billion
- Q3 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 7,151 shares of BMRN stock, worth $391,374. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,151
Previous 6,916
3.4%
Holding current value
$391,374
Previous $380,000
1.84%
% of portfolio
0.02%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding BMRN
# of Institutions
666Shares Held
182MCall Options Held
1.48MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.24 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.2MShares$833 Million0.65% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$804 Million0.46% of portfolio
-
State Street Corp Boston, MA8.76MShares$480 Million0.02% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...